Alanine prevents the inhibition of pyruvate kinase activity caused by tryptophan in cerebral cortex of rats

Metabolic Brain Disease

Volumn 18, Issue 2, 2003, Pages 129-137

  Feksa, Luciane Rosa ^a   Cornelio, Andrea Renata ^a   Vargas, Carmem Regla ^a   De Souza Wyse, Angela Terezinha ^a   Dutra Filho, Carlos Severo ^a   Wajner, Moacir ^a   Wannmacher, Clovis Milton Duval ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Alanine; Hypertryptophanemia; Pyruvate kinase; Tryptophan

Indexed keywords

ALANINE; KYNURENINE; PYRUVATE KINASE; TRYPTOPHAN;

AMINOACIDEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; CATALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; EMOTIONAL DISORDER; ENZYME ACTIVITY; ENZYME INHIBITION; GLYCOLYSIS; HYPERTRYPTOPHANEMIA; MENTAL DEFICIENCY; MOOD DISORDER; NONHUMAN; RAT; SEXUAL DYSFUNCTION;

ALANINE; ANIMALS; CEREBRAL CORTEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; NERVE TISSUE PROTEINS; PYRUVATE KINASE; RATS; RATS, WISTAR; TRYPTOPHAN;

ANIMALIA;

EID: 0037495955     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023811019023     Document Type: Article

References (24)

1. Balász, R. (1965). Control of glutamate metabolism. The effect of pyruvate. J. Neurochem. 12:63-67.
2. Baños, G., Daniel, P.M., and Pratt, O.E. (1978). The effect of age upon the entry of some amino acids into de brain and its incorporation into cerebral protein. Dev. Med. Child Neurol. 20:335-346.
3. Beal, M.F. (2000). Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci. 23: 298-304.
4. Clark, J.B., Bates, T.E., Cullingford, T., and Land, J.M. (1993). Development of enzymes of energy metabolism in the neonatal mammalian brain. Dev. Neurosci. 15:174-180.
5. Dobbing J., and Sands, J. (1979). Comparative aspects of the brain growth spurt. Early Hum. Dev. 3: 79-84.
6. Erecinska, M., Nelson, D., Nissim, I., Daikhin, Y., and Yudkoff, M. (1994). Cerebral alanine transport and alanine aminotransferase reaction: Alanine as a source of glutamate. J. Neurochem. 62:1953-1964.
7. Foster, A.C., Vezzani, A., French, E.D., and Schwarcz, R. (1984). Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci. Lett. 48:273-278.
8. Girard, J., Ferre, P., Pegorier, J.P., and Duce, P.H. (1992). Adaptations of glucose and fatty acid metabolism during perinatal period and suckling-weaning transition. Physiol. Rev. 72:507-562.
9. Himwich, H.E. (1951). Brain Metabolism and Cerebral Disorders, Williams and Wilkins, Baltimore, MD.
10. Ibsen, K.H., and Marles, S.W. (1976). Inhibition of chicken pyruvate kinases by amino acids. Biochemistry 15:1073-1079.
11. Ibsen, K.H., and Trippet, P. (1974). Effects of amino acids on the kinetic properties of three noninterconvertible rat pyruvate kinases. Arch. Biochem. Biophys. 163:570-580.
12. Joseph, M.H., and Marsden, C. (1986). Amino acids and small peptides. In (C.K, Lim, ed.), HPLC of Small Peptides, IRL Press, Oxford, pp. 13-27.
13. Leong, S.F., Lai, J.C.K., Lim, L., and Clark, J.B. (1981). Energy-metabolising enzymes in brain regions of adult and aging rats. J. Neurochem. 37:1548-1556.
14. Levy, H. L. (2001). Hartnup disorder. In (C.R, Scriver, A.L. Beaudet, W.S, Sly, and D, Valle, eds.), The Metabolic and Molecular Bases of Inherited Diseases, 8th edn, McGraw-Hill, New York, pp. 1667-1724.
15. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
16. Lütz, M.G., Feksa, L.R., Wyse, A.T.S., Dutra-Filho, C.S., Wajner, M., and Wannmacher, C.M.D. (2003). Alanine prevents the in vitro inhibition of glycolysis caused by phenylalanine in brain cortex of rats. Metab. Brain Dis. 18:87-94.
17. Marsden, D., Barshop, B. A., Capistrano-Estrada, S., Rice, M., Prodanus, C., Sartoris, D., Wolff, J., Jones, K.L., Spector, S., and Nyhan, W.L. (1994). Anabolic effect of human hormone: Management of inherited disorders of catabolic pathways. Biochem. Med. Metab. Biol. 52:145-154.
18. Martin, I.R., Mellor, C.S., and Fraser, F.C. (1995). Familial hypertryptophanemia in two siblings. Clin. Genet. 47:180-183.
19. Snedden, W., Mellor, C.S., and Martin, J.R. (1983). Familial hypertoptophanemia, tryptophanuria and indolketonuria. Clin. Chim. Acta 131:247-256.
20. Srivastava, L.K., and Baquer, N.Z. (1985). Purification and properties of rat brain pyruvate kinase. Arch. Biochem. Biophys. 236:703-713.
21. Stone, T.W., and Connick, J.H. (1985). Quinolinic acid and other kynurenines in the central nervous system. Neuroscience 15:597-617.
22. Tada, K., Ito, H., Wada, Y., and Arakawa, T. (1963). Congenital tryptophanuria with dwarfism ("H" disease-like clinical features without indicanuria and generalized aminoaciduria): A probably new inborn error of tryptophan metabolism. Tohoku J. Exp. Med. 80:118-134.
23. 1 from bovine brain. Int. J. Biochem. 21:1053-1060.
24. Vijayvargiya, R., Schwark, W.S., and Singhal, R.L. (1969). Pyruvate kinase: Modulation by L-phenylalanine and L-alanine. Can. J. Biochem. 47:895-898.